Martin Forster

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Smoking Cessation

Advanced Non Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Forster, Irene Brana, Antonio L Pousa, Bernard Doger, Patricia Roxburgh, Pawan Bajaj, Julio Antonio Peguero, Matthew G Krebs, Enric Carcereny, Grisma Patel, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Martin Forster, Irene Brana, Antonio L Pousa, Bernard Doger, Patricia Roxburgh, Pawan Bajaj, Julio Antonio Peguero, Matthew G Krebs, Enric Carcereny, Grisma Patel, Christian Mueller, Chrystelle Brignone, Frederic Triebel
Eftilagimod alpha (soluble LAG-3 protein) combined with pembrolizumab as second-line therapy for patients with metastatic head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kenrick Ng, Rob Metcalf, Joseph Sacco, Anthony Kong, Graham Wheeler, Sharon Forsyth, Reshma Bhat, Joseph Ward, Leah Ensell, Helen Lowe, Victoria Spanswick, John Hartley, Laura White, Elizabeth Lloyd-Dehler, Martin Forster
Protocol for the EACH trial: a multicentre phase II study evaluating the safety and antitumour activity of the combination of avelumab, an anti-PD-L1 agent, and cetuximab, as any line treatment for patients with recurrent/metastatic head and neck squamous cell cancer (HNSCC) in the UK. BMJ open 13 (11) (2023)